Format

Send to

Choose Destination
Curr Diab Rep. 2014 Dec;14(12):552. doi: 10.1007/s11892-014-0552-7.

Extracellular matrix components in the pathogenesis of type 1 diabetes.

Author information

1
Matrix Biology Program, Benaroya Research Institute, 1201 Ninth Avenue, Seattle, WA, 98101, USA, mbogdani@benaroyaresearch.org.

Abstract

Type 1 diabetes (T1D) results from progressive immune cell-mediated destruction of pancreatic β cells. As immune cells migrate into the islets, they pass through the extracellular matrix (ECM). This ECM is composed of different macromolecules localized to different compartments within and surrounding islets; however, the involvement of this ECM in the development of human T1D is not well understood. Here, we summarize our recent findings from human and mouse studies illustrating how specific components of the islet ECM that constitute basement membranes and interstitial matrix of the islets, and surprisingly, the intracellular composition of islet β cells themselves, are significantly altered during the pathogenesis of T1D. Our focus is on the ECM molecules laminins, collagens, heparan sulfate/heparan sulfate proteoglycans, and hyaluronan, as well as on the enzymes that degrade these ECM components. We propose that islet and lymphoid tissue ECM composition and organization are critical to promoting immune cell activation, islet invasion, and destruction of islet β cells in T1D.

PMID:
25344787
PMCID:
PMC4238291
DOI:
10.1007/s11892-014-0552-7
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center